Molecular Partners Presents Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712

Molecular Partners AG discussed clinical imaging and dosimetry data for DLL3 targeting radiotherapeutic MPO712 at the Theranostics World Conference in South Africa. The data was collected as part of a named patient access program under compassionate care laws. The presentation was led by Seth Lewis, Head of Investor Relations and Strategy.